Constitutive overexpression of human telomerase reverse transcriptase but not c-myc blocks terminal differentiation in human HaCaT skin keratinocytes

Journal of Investigative Dermatology

Volumn 121, Issue 1, 2003, Pages 110-119

  Cerezo, Ana ^a   Stark, Hans Jürgen ^a   Moshir, Sharareh ^a   Boukamp, Petra ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Differentiation markers; Organotypic cocultures; Proliferation; Telomerase

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; ONCOGENE C MYC; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TRANSCRIPTION REGULATION;

EID: 0041842714     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12304.x     Document Type: Article

References (53)

1. Arnold I, Watt FM: c-Myc activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr Biol 11:558-568, 2001
2. Artandi SE, Alson S, Tietze MK, et al: Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc Natl Acad Sci USA 99:8191-8196, 2002
3. Asselineau D, Prunieras M: Reconstruction of "simplified" skin: Control of fabrication. Br J Dermatol 111 (Suppl. 27):219-222, 1984
4. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56:645-650, 1996
5. Bachor C, Bachor OA, Boukamp P: Telomerase is active in normal gastrointestinal mucosa and not up-regulated precancerous lesions. J Cancer Res Clin Oncol 125:453-460, 1999
6. Beattie TL, Zhou W, Robinson MO, Harrington L: Functional multimerization of the human telomerase reverse transcriptase. Mol Cell Biol 21:6151-6160, 2001
7. Bell E, Ehrlich HP, Buttle DJ, Nakatsuji T: Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. Science 211:1052-1054, 1981
8. Bickenbach JR, Vormwald-Dogan V, Bachor C, Bleuel K, Schnapp G, Boukamp P: Telomerase is not an epidermal stem cell marker and is downregulated by calcium. J Invest Dermatol 111:1045-1052, 1998
9. Blasco MA: Telomerase beyond telomeres. Nature Rev 2:1-6, 2002
10. Bleuel K, Popp S, Fusenig NE, Stanbridge EJ, Boukamp P: Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc Natl Acad Sci USA 96:2065-2070, 1999
11. Bouchard C, Staller P, Eilers M: Control of cell proliferation by c-Myc. Trends Cell Biol 8:202-206, 1998
12. Boukamp P, Fusenig NE: "Trans-differentiation" from epidermal to mesenchymal/myogenic phenotype is associated with a drastic change in cell-cell and cell-matrix adhesion molecules. J Cell Biol 120:981-993, 1993
13. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-771, 1988
14. Boukamp P, Chen J, Gonzales F, Jones PA, Fusenig NE: Progressive stages of "trans-differentiation" from epidermal to mesenchymal phenotype induced by MyoD1 transfection, 5-aza-2′-deoxycytidine treatment, and selection for reduced cell attachment in the human keratinocyte line HaCaT. J Cell Biol 116:1257-1271, 1992
15. Breitkreutz D, Boukamp P, Ryle CM, Stark H-J, Roop DR, Fusenig NE: Epidermal morphogenesis and keratin expression in c-Ha-Ras-transfected tumorigenic clones of the human HaCaT cell line. Cancer Res 51:4402-4409, 1991
16. 2+. Differentiation 54:201-217, 1993
17. Breitkreutz D, Schoop VM, Mirancea N, Baur M, Stark H-J, Fusenig NE: Epidermal differentiation and basement membrane formation by HaCaT cells in surface transplants. Eur J Cell Biol 75:273-286, 1998
18. Cerezo A, Kalthoff H, Schuermann M, Schaefer B, Boukamp P: Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT. J Cell Sci 115:1305-1311, 2002
19. Chang S, DePinho RA: Telomerase extracurricular activities. Proc Natl Acad Sci USA 99:12520-12522, 2002
20. Dickson MA, Hahn WC, Ino Y, et al: Human keratinocytes that express hTERT and also bypass a p16 (INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 20:1436-1447, 2000
21. Farwell DG, Shera KA, Koop JL, et al: Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am J Pathol 156:1537-1547, 2000
22. Feng J, Funk WD, Wang S-S, et al: The human telomerase RNA component. Science 269:1236-1241, 1995
23. Figueroa R, Lindenmaier H, Hergenhahn M, Nielsen KV, Boukamp P: Telomere erosion varies during in vitro aging of normal human fibroblasts from young and adult donors. Cancer Res 60:2770-2774, 2000
24. Fuchs E: Epidermal differentiation and keratin gene expression. J Cell Sci Suppl 17:197-208, 1993
25. Gandarillas A: Epidermal differentiation, apoptosis, and senescence: Common pathways? Exp Gerontol 35:53-62, 2000
26. González-Suárez E, Samper E, Flores JM, Blasco MA: Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat Genet 26:114-117, 2000
27. González-Suárez E, Samper E, Ramírez A, Flores JM, Martín-Caballero J, Jorcano JL, Blasco MA: Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 20:2619-2630, 2001
28. Greider CW: Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA 95:90-92, 1998
29. Härle-Bachor C, Boukamp P: Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93:6476-6481, 1996
30. Howard BD, Boenicke L, Schniewind B, Henne-Bruns D, Kalthoff H: Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir. Cancer Gene Ther 7:927-938, 2000
31. Kilian A, Bowtell DDL, Abud HE, et al: Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6:2011-2019, 1997
32. Kim NW, Piatyszek MA, Prowse KR, et al: Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015, 1994
33. Maas-Szabowski N, Stark H-J, Fusenig NE: Keratinocyte growth regulation in defined organotypic cultures through IL-1-induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 114:1075-1084, 2000
34. MacKenzie IC, Fusenig NE: Regeneration of organized epithelial structure. J Invest Dermatol 81 (1 (Suppl.):189s-194s, 1983
35. Maida Y, Kyo S, Kanaya T, et al: Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway. Oncogene 21:4071-4079, 2002
36. Meyerson M, Counter CM, Eaton EN, et al: hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90:785-795, 1997
37. Nakamura TM, Morin GB, Chapman KB, et al: Telomerase catalytic subunit homologs from fission yeast and human. Science 277:955-959, 1997
38. Presland RB, Dale BA: Epithelial structural proteins of the skin and oral cavity: Function in health and disease. Crit Rev Oral Biol Med 11:383-408, 2000
39. Prowse KR, Greider CW: Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc Natl Acad Sci USA 92:4818-4822, 1995
40. Rama S, Suresh Y, Rao AJ: Regulation of telomerase during human placental differentiation: A role for TGF-β1. Mol Cel Endocrinol 182:233-248, 2001
41. Rheinwald JG, Hahn WC, Ramsey MR, et al: A two-stage, p16 (INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol Cell Biol 22:5157-5172, 2002
42. Schoop V, Mirancea N, Fusenig NE: Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. J Invest Dermatol 112:343-353, 1999
43. Sharma HW, Sokoloski JA, Perez JR, et al: Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 92:12343-12346, 1995
44. Smola H, Thiekotter G, Fusenig NE: Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 122:417-429, 1993
45. Stewart SA, Hahn WC, O'Connor BF, et al: Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci USA 99:12606-72611, 2002
46. Waikel RL, Kawachi Y, Waikel PA, Wang XJ, Roop DR: Deregulated expression of c-Myc depletes epidermal stem cells. Nat Genet 28:165-168, 2001
47. Wang J, Xie LY, Allan S, Beach D, Hannon G: Myc activates telomerase. Genes Dev 12:1769-1774, 1998
48. Wang J, Hannon GJ, Beach DH: Risky immortalization by telomerase. Nature 405:755-756, 2000
49. Watt FM: Role of integrins in regulating epidermal adhesion, growth and differentiation. EMBO J 21:3919-3926, 2002
50. Wright WE, Piatyszek MA, Rayney WE, Byrd W, Shay J: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179, 1996
51. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R: Direct activation of TERT transcription by c-Myc. Nat Genet 21:220-224, 1999
52. Xu D, Gruber A, Björkholm M, Peterson C, Pisa P: Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: Regulatory mechanisms. Br J Cancer 80:1156-1161, 1999
53. Yamada O, Takanashi M, Ujihara M, Mizoguchi H: Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change. Leuk Res 8:711-717, 1998